GR20030100286A - Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεις - Google Patents

Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεις

Info

Publication number
GR20030100286A
GR20030100286A GR20030100286A GR2003100286A GR20030100286A GR 20030100286 A GR20030100286 A GR 20030100286A GR 20030100286 A GR20030100286 A GR 20030100286A GR 2003100286 A GR2003100286 A GR 2003100286A GR 20030100286 A GR20030100286 A GR 20030100286A
Authority
GR
Greece
Prior art keywords
pregnancy
pregnant women
pharmaceutical dosage
friendly
apt
Prior art date
Application number
GR20030100286A
Other languages
English (en)
Other versions
GR1004641B (el
Inventor
Gervais�Eric�
Atanackovic�Gordana�
Hebert�Raymond�
Original Assignee
Duchesnay�Inc@��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duchesnay�Inc@�� filed Critical Duchesnay�Inc@��
Publication of GR20030100286A publication Critical patent/GR20030100286A/el
Publication of GR1004641B publication Critical patent/GR1004641B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ίαΑμορφήΑφαρμακευτικήςΑδοσολογίαςΑπουΑπεριλαμβα΄νειΑτουλάχιστονΑέναΑεεργόΑσυστατικόΑκαιΑπρορίζεταιΑγιαΑχορήγησηΑσεΑέγκυεςΑγυναίκες@ΑΗΑμορφήΑφαρμακευτικήςΑδοσολογίαςΑφέρειΑφιλικέςΑπροςΑτηνΑκύησηΑενδείξειςΑπουΑμπορούνΑναΑβελτιώσεουνΑτηΑσυμμόρφωσηΑτωνασθενώνΑμεΑιατρικάΑσυνιστώμενεςΑμορφέςΑθεραπευτικήςΑαγωγήςΑμεΑφάρμακαΑπουΑοδηγούνΑσεΑβελτιωμένηΑαποτελεσματικότηταΑτωνΑπροϊόντων@ΑΟιΑφιλικεςΑπροςΑτηνΑκύησηΑενδείξειςςΑμπορείΑναΑμειώνουνΑταΑσυμβάνταΑεσφαλμένηςΑδιανομήςΑήΑεσφαλμένηςΑαπορροφήσεωςΑμορφώνΑφαρμακευτικήςΑδοσολογίαςΑπουΑδενΑπροορίζονταιΑγιαΑέγκυεςΑγυναίκες@ΑΕπίσηςΑαποκαλύπτεταιΑμίαΑμέθοδοςΑγιαΑτηΑμείωσηΑτωνΑσυμβαντωνΑεσφαλμένηςΑδιανομήςΑήΑεσφαλμένηςΑαπορροφήσεωςΑμορφώνΑδοσολογίαςΑπουΑδενΑπροορίζονταιΑγιαΑεέγκυεςΑγυναίκες@ΑΟιΑενΑλόγωΑμέθοδοιΑπεριλαμβανουνΑτηνΑπαροχήΑμιαςΑμορφήςΑφαρμακευτικήςΑδοσολογίαςΑπουΑπροορίζεταιΑγιαΑχρήσηΑαπόΑέγκυεςΑγυναίκεςΑηΑοποίαΑφέρειΑφιλικέςΑπροςΑτηνΑκύησηΑενδείξειςΑπουΑμπορούνΑναΑδιακρίνουνΑγραφικώςΑτιςΑμορφέςΑδοσολογίαςΑοιΑοποίεςΑπροορίζονταιΑγιαΑχρήσηΑκατάΑτηνΑκύησηΑαπόΑτιςΑάλλες@ΑΑΑΰ
GR20030100286A 2002-07-05 2003-07-02 Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα GR1004641B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002392486A CA2392486A1 (en) 2002-07-05 2002-07-05 Pharmaceutical dosage form bearing pregnancy-friendly indicia

Publications (2)

Publication Number Publication Date
GR20030100286A true GR20030100286A (el) 2004-03-19
GR1004641B GR1004641B (el) 2004-07-23

Family

ID=4171184

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20030100286A GR1004641B (el) 2002-07-05 2003-07-02 Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα

Country Status (12)

Country Link
US (3) US7560122B2 (el)
AU (1) AU2003245774A1 (el)
BE (1) BE1016043A5 (el)
CA (1) CA2392486A1 (el)
FR (1) FR2841783A1 (el)
GR (1) GR1004641B (el)
IE (1) IE20030484A1 (el)
IT (1) ITUD20030145A1 (el)
MC (1) MC200066A1 (el)
NL (1) NL1023797C2 (el)
TW (1) TW200400835A (el)
WO (1) WO2004004694A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
EP2787971A4 (en) 2012-02-22 2015-04-29 Duchesnay Inc FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND / OR THEIR METABOLITES OR SALTS
MX366760B (es) 2013-07-22 2019-07-23 Duchesnay Inc Composición para la gestión de las náuseas y los vómitos.
WO2017029573A1 (en) * 2015-08-17 2017-02-23 Aequus Pharmaceuticals Inc. Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride
AR121619A1 (es) * 2020-03-25 2022-06-22 Inibsa Ginecologia S A Una forma de dosificación oral de múltiples unidades de liberación modificada de succinato de doxilamina y clorhidrato de piridoxina y un procedimiento para su preparación

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778984A (en) * 1985-10-16 1988-10-18 Canon Denshi Kabushiki Kaisha Apparatus for detecting focus from astigmatism
US4788984A (en) 1987-01-30 1988-12-06 Procare Industries Ltd. Method and kit for use in conceiving a child of a desired gender
US5290799A (en) 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
PT533280E (pt) 1991-09-20 2001-01-31 Glaxo Group Ltd Novas utilizacoes medicas para antagonistas de taquiquinina
CA2081679A1 (en) 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5457895A (en) * 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US6352713B1 (en) * 1999-12-01 2002-03-05 Drugtech Corporation Nutritional composition
US5443288A (en) * 1994-07-25 1995-08-22 Miles; Barbara L. Pregnancy advent calendar
US5531230A (en) * 1995-07-14 1996-07-02 Bell; Ray W. Strap secured condom
PT910346E (pt) * 1996-06-17 2004-07-30 Janssen Pharmaceutica Nv Marcacao de formas galenicas de desintegracao rapida
US6226564B1 (en) * 1996-11-01 2001-05-01 John C. Stuart Method and apparatus for dispensing drugs to prevent inadvertent administration of incorrect drug to patient
US5836890A (en) * 1997-05-30 1998-11-17 Joseph N. Jackson Apparatus and method of providing a personal fertility predictor
UA57811C2 (uk) 1997-11-21 2003-07-15 Пфайзер Продактс Інк. Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності
BR9908190A (pt) 1998-02-24 2000-10-24 Univ Wake Forest Processos para tratar a dor especìfica de fêmea em um paciente fêmea, e para tratar a dor crÈnica em um paciente
DE69912379T2 (de) 1998-08-14 2004-05-06 Pfizer Inc. Antithrombosemittel
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US6223559B1 (en) * 1999-07-20 2001-05-01 Shelia J. Coleman Medical identification charm bracelet
DE60109081T2 (de) * 2000-04-26 2006-04-06 Shin-Etsu Chemical Co., Ltd. Feste Zubereitung mit einem zwei- oder mehrfarbigen Filmüberzug
US6701035B2 (en) * 2000-12-14 2004-03-02 Hewlett-Packard Development Company, L.P. Electric-field actuated chromogenic materials based on molecules with a rotating middle segment for applications in photonic switching
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
CA103771S (en) * 2003-07-22 2006-01-18 Duchesnay Inc Pharmaceutical dosage form

Also Published As

Publication number Publication date
NL1023797C2 (nl) 2004-03-10
US20110059026A1 (en) 2011-03-10
AU2003245774A1 (en) 2004-01-23
NL1023797A1 (nl) 2004-01-06
US7560122B2 (en) 2009-07-14
WO2004004694A1 (en) 2004-01-15
MC200066A1 (fr) 2004-03-03
FR2841783A1 (fr) 2004-01-09
US20060159750A1 (en) 2006-07-20
ITUD20030145A1 (it) 2004-01-06
CA2392486A1 (en) 2002-12-08
GR1004641B (el) 2004-07-23
BE1016043A5 (fr) 2006-02-07
TW200400835A (en) 2004-01-16
US20040091526A1 (en) 2004-05-13
IE20030484A1 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
Chapman et al. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day− 1) in the treatment of cutaneous or lymphocutaneous sporotrichosis
EP2248519A3 (en) Non-mucoadhesive film dosage forms
HUP0203588A2 (hu) Fájdalomcsillapító hatású gyógyszerkészítmények és alkalmazásuk
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
Burkman Transdermal hormonal contraception: benefits and risks
MXPA05007158A (es) Formulacion farmaceutica con un agente activo insoluble.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
RS20090134A (en) Pharmaceutical combinattion of ethinylestradiol and drospinenone for use as a contraceptive
SG146638A1 (en) Pharmaceutical delivery system
JP2010520246A5 (el)
MX2007013137A (es) Regimen anticonceptivo con dosificacion de estrogeno ampliada.
MA27723A1 (fr) Trousse utilisable a des fins pharmaceutiques
Kondreddy et al. Effectiveness of a controlled release chlorhexidine chip (PerioCol™-CG) as an adjunctive to scaling and root planing when compared to scaling and root planing alone in the treatment of chronic periodontitis: A comparative study
BR0211198A (pt) Composições farmacêuticas e seu uso
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
JP2017520518A (ja) ヒト女性生殖器の外陰部領域を襲う痛みを局所的に治療するためのデバイスおよび製剤
GR20030100286A (el) Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεις
CO5241355A1 (es) Forma envasada de composiciones farmaceuticas nucleosidicas activas para vacunas contra la hepatitis
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
Seger et al. Position paper: cathartics
Vensel Fluconazole: a valuable fungistatic
UA81387C2 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
Friedlander et al. Diaper Dermatitis--Appropriate Evaluation & Optimal Management Strategies.